EUVIMEDEUVIMED entdecken
Open Access

Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort

Shailja C Shah iD, M Constanza Camargo iD, Mark Lamm, Ranier Bustamante, Christianne L Roumie, Otis Wilson, Alese E Halvorson iD, Robert Greevy iD, Lin Liu, Samir Gupta iD, Joshua Demb iD

Journal of Clinical Oncology · 2024

DOI: 10.1200/jco.23.00703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Shailja C Shah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, VA San Diego Healthcare System, San Diego, CA. Hauptthemen laut MEDLINE: Helicobacter Infections, Colorectal Neoplasms, Helicobacter pylori. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NCI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Helicobacter pylori is the most common cause of infection-associated cancer worldwide. We aimed to evaluate the impact of H. pylori infection and treatment on colorectal cancer (CRC) incidence and mortality. PATIENTS US Veterans who completed H. pylori testing between 1999 and 2018. METHODS We conducted a retrospective cohort analysis among adults within the Veterans Health Administration who completed testing for H. pylori. The primary exposures were (1) H. pylori test result (positive/negative) and (2) H. pylori treatment (untreated/treated) among H. pylori–positive individuals. The primary outcomes were CRC incidence and mortality. Follow-up started at the first H. pylori testing and continued until the earliest of incident or fatal CRC, non-CRC death, or December 31, 2019. RESULTS Among 812,736 individuals tested for H. pylori, 205,178 (25.2%) tested positive. Being H. pylori–positive versus H. pylori–negative was associated with higher CRC incidence and mortality. H. pylori treatment versus no treatment was associated with lower CRC incidence and mortality (absolute risk reduction 0.23%-0.35%) through 15-year follow-up. Being H. pylori–positive versus H. pylori–negative was associated with an 18% (adjusted hazard ratio [adjusted HR], 1.18 [95% CI, 1.12 to 1.24]) and 12% (adjusted HR, 1.12 [95% CI, 1.03 to 1.21]) higher incident and fatal CRC risk, respectively. Individuals with untreated versus treated H. pylori infection had 23% (adjusted HR, 1.23 [95% CI, 1.13 to 1.34]) and 40% (adjusted HR, 1.40 [95% CI, 1.24 to 1.58]) higher incident and fatal CRC risk, respectively. The results were more pronounced in the analysis restricted to individuals with nonserologic testing. CONCLUSION H. pylori positivity may be associated with small but statistically significant higher CRC incidence and mortality; untreated individuals, especially those with confirmed active infection, appear to be most at risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsColorectal NeoplasmsHelicobacter pyloriHumansMaleFemaleMiddle AgedRetrospective StudiesAgedIncidenceUnited StatesAnti-Bacterial AgentsCohort StudiesAdult

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Gastroenterology, VA San Diego Healthcare System, San Diego, CA.
  • Division of Gastroenterology, University of California, San Diego, San Diego, CA.
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD.
  • Department of Medicine, VA Tennessee Valley Healthcare System, Clinical Services Research and Development, Nashville, TN.
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN.
  • Department of Medicine, VA Geriatrics Research Education and Clinical Center (GRECC), VA Tennessee Valley Health System, Nashville, TN.

ORCID-Profile: Shailja C Shah, M Constanza Camargo, Alese E Halvorson, Robert Greevy, Samir Gupta, Joshua Demb

Förderung

  • CSRD VA
  • NCI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Shah, S. C., Camargo, M. C., Lamm, M., Bustamante, R., Roumie, C. L., Wilson, O., Halvorson, A. E., Greevy, R., Liu, L., Gupta, S., & Demb, J. (2024). Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort. Journal of Clinical Oncology. https://doi.org/10.1200/jco.23.00703

Vancouver

Shah SC, Camargo MC, Lamm M, Bustamante R, Roumie CL, Wilson O, et al. Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort. Journal of Clinical Oncology. 2024. doi:10.1200/jco.23.00703

BibTeX
@article{Shah2024,
  author = {Shah, Shailja C and Camargo, M Constanza and Lamm, Mark and Bustamante, Ranier and Roumie, Christianne L and Wilson, Otis and Halvorson, Alese E and Greevy, Robert and Liu, Lin and Gupta, Samir and Demb, Joshua},
  title = {Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1200/jco.23.00703}
}
Kostenlos starten →